Total Payments
$1,428
2024 Payments
$101.95
Companies
19
Transactions
90
Medicare Patients
313
Medicare Billing
$25,761
Payment Breakdown by Category
Food & Beverage$1,428 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,428 | 90 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $269.00 | 18 | $0 (2024) |
| Lilly USA, LLC | $172.05 | 11 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $109.03 | 7 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $106.35 | 8 | $0 (2024) |
| Amarin Pharma Inc. | $101.27 | 7 | $0 (2021) |
| Merck Sharp & Dohme LLC | $89.84 | 6 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $87.75 | 5 | $0 (2023) |
| ABBVIE INC. | $84.71 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $84.62 | 4 | $0 (2024) |
| Astellas Pharma US Inc | $82.94 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $101.95 | 5 | Novartis Pharmaceuticals Corporation ($47.83) |
| 2023 | $242.27 | 13 | Otsuka America Pharmaceutical, Inc. ($73.84) |
| 2022 | $88.36 | 6 | Lilly USA, LLC ($28.60) |
| 2021 | $215.80 | 13 | Novo Nordisk Inc ($57.21) |
| 2020 | $281.18 | 19 | Novo Nordisk Inc ($91.07) |
| 2019 | $160.25 | 11 | AstraZeneca Pharmaceuticals LP ($42.31) |
| 2018 | $173.38 | 11 | Novo Nordisk Inc ($88.53) |
| 2017 | $164.96 | 12 | Lilly USA, LLC ($46.40) |
All Payment Transactions
90 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Diabetes | ||||||
| 05/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Respiratory | ||||||
| 12/07/2023 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Endocrinology | ||||||
| 11/02/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: PSYCHIATRY | ||||||
| 10/06/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Cardio-renal | ||||||
| 08/07/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/24/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Neuroscience | ||||||
| 07/06/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: PSYCHIATRY | ||||||
| 06/22/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: PSYCHIATRY | ||||||
| 03/24/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: PSYCHIATRY | ||||||
| 03/09/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardio-renal | ||||||
| 01/10/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: PSYCHIATRY | ||||||
| 09/08/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Neuroscience | ||||||
| 09/08/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Neuroscience | ||||||
| 07/07/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: NEUROSCIENCE | ||||||
| 05/26/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: RESPIRATORY | ||||||
| 05/23/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $14.60 | General |
| Category: Pain Management | ||||||
| 12/09/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 63 | 122 | $17,010 | $7,359 |
| 2022 | 2 | 59 | 98 | $13,370 | $6,361 |
| 2021 | 3 | 69 | 129 | $14,125 | $5,527 |
| 2020 | 3 | 122 | 252 | $24,460 | $6,514 |
Total Patients
313
Total Services
601
Medicare Billing
$25,761
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 78 | $9,750 | $4,192 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 44 | $7,260 | $3,167 | 43.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 70 | $8,750 | $3,913 | 44.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 28 | $4,620 | $2,448 | 53.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 89 | $11,125 | $5,180 | 46.6% |
| Q3014 | Telehealth originating site facility fee | Office | 2021 | 12 | 20 | $1,300 | $237.82 | 18.3% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2021 | 12 | 20 | $1,700 | $109.15 | 6.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 50 | 111 | $13,875 | $4,515 | 32.5% |
| Q3014 | Telehealth originating site facility fee | Office | 2020 | 36 | 70 | $4,550 | $1,306 | 28.7% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 36 | 71 | $6,035 | $693.41 | 11.5% |
About Dr. David Berwald, MD
Dr. David Berwald, MD is a Surgery healthcare provider based in Bridgeton, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811084734.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Berwald, MD has received a total of $1,428 in payments from pharmaceutical and medical device companies, with $101.95 received in 2024. These payments were reported across 90 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,428).
As a Medicare-enrolled provider, Berwald has provided services to 313 Medicare beneficiaries, totaling 601 services with total Medicare billing of $25,761. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgery
- Other Specialties General Practice
- Location Bridgeton, MO
- Active Since 10/10/2006
- Last Updated 03/01/2012
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1811084734
Products in Payments
- Ozempic (Drug) $175.71
- XARELTO (Drug) $109.03
- Vascepa (Drug) $101.27
- TRULICITY (Drug) $82.10
- FARXIGA (Drug) $79.03
- LEQVIO (Drug) $71.75
- REXULTI (Drug) $70.17
- MYRBETRIQ (Drug) $62.93
- Tresiba (Drug) $53.38
- Kerendia (Drug) $51.24
- UBRELVY (Drug) $49.87
- EMGALITY (Drug) $44.27
- JANUVIA (Drug) $44.00
- NEXLETOL (Drug) $37.23
- VRAYLAR (Drug) $34.84
- XIFAXAN (Drug) $33.45
- BELSOMRA (Drug) $31.85
- TRULANCE (Drug) $29.57
- Korlym (Drug) $22.18
- Myrbetriq (Drug) $20.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Bridgeton
Betsy Krebs, D.o, D.O
Surgery — Payments: $33,038
Surgery $33,038
Dr. Andrea Schwoerer, M.d, M.D
Surgery — Payments: $21,508
Surgery $21,508
Mario Morales, Md, MD
Surgery — Payments: $18,209
Surgery $18,209
Jacob Jackson, D.o, D.O
Surgery — Payments: $9,591
Surgery $9,591
Dr. Thomas Charles, M.d, M.D
Surgery — Payments: $8,285
Surgery $8,285
Dr. Kyle Christensen, D.o, D.O
Surgery — Payments: $6,385
Surgery $6,385